TerrAscend Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Ziad Ghanem
- Full Time Employees
- 950
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 77 City Centre Drive, East Tower Mississauga ON Canada L5B 1M5
- IPO Date
- Nov 17, 2017
- CIK
- 0001778129
- Website
- terrascend.com
- Similar Companies
- Business
- TerrAscend Corp. is a leading North American cannabis operator engaged in vertically integrated cultivation, processing, manufacturing, and retail distribution, with a multi-state footprint in the United States and retail operations in Canada. Founded in 2017 and headquartered in King of Prussia, Pennsylvania, the company pursues a diversified platform across medical and adult-use markets, supported by cultivation facilities, manufacturing capabilities, and a network of dispensaries under brand names such as The Apothecarium and GAGE Cannabis. Main products and services - Vertical integration across the cannabis supply chain: cultivation of cannabis flower; processing and manufacturing of finished cannabis products; development and production of value-added offerings including concentrates, edibles, and other consumer formats; packaging and quality control aligned with state regulatory standards. - Retail and distribution: ownership and operation of cannabis dispensaries across core markets; direct-to-consumer sales through company-operated storefronts in the United States and Canada; product assortment spanning flower, concentrates, edibles, topicals, and ancillary accessories. - Product development and licensing: development of proprietary product lines and partnerships with licensed brands; exclusive or strategic licensing arrangements in certain markets to expand brand portfolio and consumer access. - Compliance and quality systems: adherence to state-by-state regulatory frameworks for licensing, testing, labeling, and compliance; integration of supply chain controls to ensure consistency and safety across products and markets. Latest major company changes - Strategic expansion and portfolio optimization across multiple U.S. states, extending vertical integration and retail footprint; ongoing enhancements to manufacturing capacity and distribution capabilities to support broader product offerings. - Acquisition-orientation and partnerships: engages in strategic alliances and potential acquisitions to expand market presence, product lines, and regulatory-compliant operations in new jurisdictions. - Market leadership initiatives: continued investments in branded retail formats and in-market expansion to strengthen leadership position in Michigan and other Midwest markets, as well as in California and Pennsylvania where licensed operations are active. - Corporate governance and organizational adjustments: alignment of leadership and governance to support growth in a multi-state operating model; potential restructuring or reorganizations to optimize operational efficiency and capital deployment. Additional context - Industry and segments: cannabis cultivation, processing, manufacturing, and retail; medical and adult-use markets; branded consumer products and white-label manufacturing. - Target markets: medical patients and adult-use consumers in North America; emphasis on regulated markets with multi-state operations and cross-border retail exposure in Canada. - Geographic operations: United States—California, Maryland, New Jersey, Ohio, Pennsylvania (with retail in additional states); Canada—retail presence and distribution; headquarters in the United States (King of Prussia, Pennsylvania). - Founding year and headquarters: founded in 2017; headquarters in King of Prussia, Pennsylvania. - Subsidiaries/relationships: operates multiple dispensaries under recognized brand names (e.g., The Apothecarium, GAGE Cannabis) and maintains vertically integrated facilities for cultivation, processing, and manufacturing; listed as a North American cannabis operator with multi-state platforms and retail networks.
TerrAscend to Host Second Quarter 2026 Earnings Conference Call
TerrAscend Signs Agreement to Acquire Fifth Dispensary in New Jersey
TerrAscend Files Preliminary Proxy Statement for Special Meeting of Shareholders in Preparation for Uplisting to US Exchange
TerrAscend Completes Oversubscribed Debt Financing, Raising $21.7 Million
TerrAscend Announces Results of Annual General Meeting
TerrAscend Corp. (TSND:CA) Shareholder/Analyst Call Prepared Remarks Transcript
TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting
TerrAscend Reports First Quarter 2026 Financial Results
TerrAscend Reports First Quarter 2026 Financial Results
TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call
TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call
TerrAscend (OTCMKTS:TSNDF) Trading 4% Higher – What’s Next?
TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis
TerrAscend Corp. (TSND:CA) Q4 2025 Earnings Call Transcript
TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results
TerrAscend Increases Retail Footprint in New Jersey with Closing of Union Chill Dispensary Transaction
TerrAscend (OTCMKTS:TRSSF) Stock Price Down 3.9% – Here’s Why
Mike Tyson and TerrAscend Team Up To Launch Tyson 2.0 In Maryland And Pennsylvania
TerrAscend Corp. (TSND:CA) Q3 2025 Earnings Call Transcript
TerrAscend Corp. (TSNDF) Reports Q3 Loss, Lags Revenue Estimates